Suchergebnisse - "Lardy-Cléaud, Audrey"

PubPharm (25)

1

Impact of the time of initiation and line of biologic therapy on the retention rate of secukinumab in axial spondyloarthritis (axSpA) : data from the French multicentre retrospective FORSYA study

enthalten in: RMD open | 2024

von Dougados, M. | Lardy-Cléaud, A. | Desfleurs, E. | +7

2

Long-Term Results with Everolimus in Advanced Hormone Receptor Positive Breast Cancer in a Multicenter National Real-World Observational Study

enthalten in: Cancers | 2023

von François-Martin, H. | Lardy-Cléaud, A. | Pistilli, B. | +20

3

Impact of early palliative care on additional line of chemotherapy in metastatic breast cancer patients : results from the randomized study OSS

enthalten in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | 2022

von Chvetzoff, G. | Bouleuc, C. | Lardy-Cléaud, A. | +14

4

Impact of early palliative care on additional line of chemotherapy in metastatic breast cancer patients: results from the randomized study OSS

enthalten in: Supportive care in cancer | 2022

von Chvetzoff, G. | Bouleuc, C. | Lardy-Cléaud, A. | +14

5

Impact of early palliative care on additional line of chemotherapy in metastatic breast cancer patients: results from the randomized study OSS

enthalten in: Supportive care in cancer | 2022

von Chvetzoff, G. | Bouleuc, C. | Lardy-Cléaud, A. | +14

6

Alterations in Homologous Recombination-Related Genes and Distinct Platinum Response in Metastatic Triple-Negative Breast Cancers : A Subgroup Analysis of the ProfiLER-01 Trial

enthalten in: Journal of personalized medicine | 2022

von Bonnet, E. | Haddad, V. | Quesada, S. | +22

7

Low level of Fibrillarin, a ribosome biogenesis factor, is a new independent marker of poor outcome in breast cancer

enthalten in: BMC cancer | 2022

von Nguyen Van Long, F. | Lardy-Cleaud, A. | Carène, D. | +28

8

Low level of Fibrillarin, a ribosome biogenesis factor, is a new independent marker of poor outcome in breast cancer

enthalten in: BMC cancer | 2022

von Nguyen Van Long, F. | Lardy-Cleaud, A. | Carène, D. | +28

9

Progression-free survival on endocrine therapy, before or after chemotherapy, in hormone receptor-positive HER2-negative metastatic breast cancer

enthalten in: Breast cancer research and treatment | 2022

von Corbaux, P. | Lardy-Cleaud, A. | Alexandre, M. | +17

10

Therapeutic Challenges in Patients with Gynecologic Carcinosarcomas : Analysis of a Multicenter National Cohort Study from the French Prospective TMRG Network

enthalten in: Cancers | 2022

von Romeo, C. | Le Saux, O. | Jacobs, M. | +22